[ Price : $8.95]
FDA grants Elixir Medical a breakthrough device designation for its DynamX Sirolimus-Eluting Coronary Bioadaptor System for use in...[ Price : $8.95]
FDA extends by three months its review of a Syndax Pharmaceuticals NDA for revumenib and its use in treating adult and pediatric p...[ Price : $8.95]
FDA approves Guardant Healths Shield blood test for colon cancer screening in adults 45 years of age and older who are at average ...[ Price : $8.95]
A January inspection of Brassica Pharmas Indian sterile drug manufacturing facility leads to a 10-observation Form FDA-483 that ci...[ Price : $8.95]
FDA approves a Sun Pharmaceutical Industries NDA for Leqselvi (deuruxolitinib) 8 mg tablets for treating adults with severe alopec...[ Price : $8.95]
Federal Register notice: FDA announces the renewal for two years of its Pulmonary-Allergy Drugs Advisory Committee.[ Price : $8.95]
Federal Register notice: FDA announces a 9/18 Pediatric Advisory Committee meeting that will discuss post-marketing pediatric-focu...[ Price : $8.95]
FDA warns about adverse event reports it has received that may be related to overdoses due to dosing errors associated with compou...